{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:19:49Z","timestamp":1777634389191,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32002307"],"award-info":[{"award-number":["32002307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejps.2023.106613","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T11:39:34Z","timestamp":1697629174000},"page":"106613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Toltrazuril alkalizer-modifying solid dispersions against Toxoplasma gondii: A pharmacotechnical strategy to improve the efficacy of the drug"],"prefix":"10.1016","volume":"191","author":[{"given":"Weiwei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bohan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoliang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2023.106613_bib0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Design Develop. Therapy"},{"issue":"9","key":"10.1016\/j.ejps.2023.106613_bib0002","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.xphs.2018.04.028","article-title":"Nikolakakis I. Evaluation of spironolactone solid dispersions prepared by co-spray drying with soluplus\u00ae and polyvinylpyrrolidone and influence of tableting on drug release","volume":"107","author":"Al-Zoubi","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106613_bib0003","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ejps.2023.106613_bib0004","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","article-title":"Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies","volume":"11","author":"Bhujbal","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"7","key":"10.1016\/j.ejps.2023.106613_bib0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/03639045.2021.1908342","article-title":"Ternary solid dispersions: classification and formulation considerations","volume":"47","author":"Borde","year":"2021","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"6","key":"10.1016\/j.ejps.2023.106613_bib0006","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.xphs.2022.01.007","article-title":"Industry white paper: contemporary opportunities and challenges in characterizing crystallinity in amorphous solid dispersions","volume":"111","author":"Chasse","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2023.106613_bib0007","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.3389\/fmicb.2018.02108","article-title":"Prevalence, risk factors, and genotypes of Toxoplasma gondii in food animals and humans (2000-2017) from China","volume":"9","author":"Dong","year":"2018","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106613_bib0008","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2307\/3285739","article-title":"Infection and immunity with the RH strain of Toxoplasma gondii in rats and mice","volume":"85","author":"Dubey","year":"1999","journal-title":"J. Parasitol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106613_bib0009","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2004.11.005","article-title":"Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50\/13","volume":"60","author":"Fini","year":"2005","journal-title":"Eur. J. Pharmac. Biopharmac."},{"issue":"5","key":"10.1016\/j.ejps.2023.106613_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/j.ejps.2023.106613_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119439","article-title":"Development of mirtazapine loaded solid lipid nanoparticles for topical delivery: optimization, characterization and cytotoxicity evaluation","volume":"586","author":"Kaur","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106613_bib0012","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ijpara.2008.06.002","article-title":"Control of the risk of human toxoplasmosis transmitted by meat","volume":"38","author":"Kijlstra","year":"2008","journal-title":"Int. J. Parasitol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106613_bib0013","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0939-6411(00)00076-X","article-title":"Improving drug solubility for oral delivery using solid dispersions","volume":"50","author":"Leuner","year":"2000","journal-title":"Eur. J. Pharmac. Biopharmaceut."},{"issue":"9","key":"10.1016\/j.ejps.2023.106613_bib0014","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3109\/03639045.2015.1018274","article-title":"Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques","volume":"41","author":"Meng","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejps.2023.106613_bib0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s13346-015-0256-9","article-title":"Amorphous solid dispersion technique for improved drug delivery: basics to clinical applications","volume":"5","author":"Mishra","year":"2015","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejps.2023.106613_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.aca.2012.10.015","article-title":"Development of an analytical methodology for the determination of the antiparasitic drug toltrazuril and its two metabolites in surface water, soil and animal manure","volume":"755","author":"Olsen","year":"2012","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejps.2023.106613_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ijpharm.2012.07.015","article-title":"Manufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerations","volume":"453","author":"Paudel","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejps.2023.106613_bib0018","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/jps.21052","article-title":"Measurement of surface pH of pharmaceutical solids: a critical evaluation of indicator dye-sorption method and its comparison with slurry pH method","volume":"97","author":"Pudipeddi","year":"2008","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2023.106613_bib0019","doi-asserted-by":"crossref","DOI":"10.1515\/jbcpp-2019-0244","article-title":"Ternary solid dispersion to improve solubility and dissolution of meloxicam","volume":"30","author":"Setyawan","year":"2019","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2023.106613_bib0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2006.02.021","article-title":"Strategies for the design of hydrophilic matrix tablets with controlled microenvironmental pH","volume":"316","author":"Siepe","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106613_bib0021","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2014.881798","article-title":"Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility","volume":"11","author":"Taniguchi","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2023.106613_bib0022","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejpb.2008.12.009","article-title":"Dissolution-modulating mechanism of alkalizers and polymers in a nanoemulsifying solid dispersion containing ionizable and poorly water-soluble drug","volume":"72","author":"Tran","year":"2009","journal-title":"Eur. J. Pharmaceut. Biopharmaceut."},{"issue":"2","key":"10.1016\/j.ejps.2023.106613_bib0023","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.xphs.2018.09.019","article-title":"Development of solid dispersion by hot melt extrusion using mixtures of polyoxylglycerides with polymers as carriers for increasing dissolution rate of a poorly soluble drug model","volume":"108","author":"Vasoya","year":"2019","journal-title":"J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejps.2023.106613_bib0024","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejps.2023.106613_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-5173(01)00741-4","article-title":"In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions","volume":"225","author":"Zerrouk","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2023.106613_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.126061","article-title":"Sulfonamide antibiotics sorption by high silica ZSM-5: effect of pH and humic monomers (vanillin and caffeic acid)","volume":"248","author":"Zuo","year":"2020","journal-title":"Chemosphere"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:10:32Z","timestamp":1760530232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":26,"alternative-id":["S0928098723002439"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106613","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toltrazuril alkalizer-modifying solid dispersions against Toxoplasma gondii: A pharmacotechnical strategy to improve the efficacy of the drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106613"}}